Health Canada
Symbol of the Government of Canada
Consumer Product Safety

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2008-4976

2. Registrant Information.

Registrant Reference Number: Prosar case 1-16401459

Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation

Address: 400 Plaza Drive

City: Secaucus

Prov / State: New Jersey

Country: USA

Postal Code: 07094-3688

3. Select the appropriate subform(s) for the incident.

Domestic Animal

4. Date registrant was first informed of the incident.


5. Location of incident.


Prov / State: ARIZONA

6. Date incident was first observed.


Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.


PMRA Registration No.       PMRA Submission No.       EPA Registration No. 2596-78

Product Name: UltraGuard Flea and Tick Powder for Cats 4 oz

  • Active Ingredient(s)
      • Guarantee/concentration 3.3 %

7. b) Type of formulation.


Application Information

8. Product was applied?


9. Application Rate.


10. Site pesticide was applied to (select all that apply).

Site: Animal / Usage sur un animal domestique

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

The reporter applied a feline product to her 7 week old puppy on 7/15/08. The product is designed to be used on pets at least 12 weeks of age. In addition, the product is designed to be used on cats and kittens, not dogs and puppies.

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?


Subform III: Domestic Animal Incident Report

1. Source of Report

Animal's Owner

2. Type of animal affected

Dog / Chien

3. Breed


4. Number of animals affected


5. Sex


6. Age (provide a range if necessary )


7. Weight (provide a range if necessary )



8. Route(s) of exposure


9. What was the length of exposure?

Unknown / Inconnu

10. Time between exposure and onset of symptoms

>30 min <=2 hrs / >30 min <=2 h

11. List all symptoms


  • General
    • Symptom - Abnormal behaviour
    • Specify - "Acting funny"
  • Nervous and Muscular Systems
    • Symptom - Seizure
    • Symptom - Confusion
  • Gastrointestinal System
    • Symptom - Salivating excessively
  • General
    • Symptom - Lethargy
    • Symptom - Hypothermia
    • Symptom - Death

12. How long did the symptoms last?

Persisted until death

13. Was medical treatment provided? Provide details in question 17.


14. a) Was the animal hospitalized?


14. b) How long was the animal hospitalized?


Day(s) / Jour(s)

15. Outcome of the incident


16. How was the animal exposed?

Treatment / Traitement

17. Provide any additional details about the incident

(eg. description of the frequency and severity of the symptoms

1-16401459: The reporter called on 7/15/08 to report the application of a feline topical flea and tick product containing the active ingredient Tetrachlorvinphos to her 7 week old puppy. According to the reporter, she had applied the product about 2 hours prior to the call. The puppy had licked the product and then had begun to ┐┐┐act funny┐┐┐, had gotten very quiet, and then had had a seizure. By the time of the call the puppy was acting confused and scared, had developed excessive salivation, and had begun to act lethargic. Prior to the call the reporter had bathed the puppy with dish soap and had called a veterinarian, who had recommended the reporter call the registrant. The reporter wondered if there was anything else she needed to do. A recommendation was made to bathe the puppy again, to follow-up with a veterinarian if the seizures continued, and to consult with a veterinarian before using any other flea and tick products. The reporter called again on 7/16. The toxic profile of the product and antidotes were discussed. A follow-up call was placed on 7/22. When contact with the reporter was re-established on 7/24, the reporter stated she had taken the puppy to her veterinarian on 7/15. According to the reporter, her veterinarian had determined the puppy┐┐┐s heart rate and respiratory rate were normal, and had indicated that the puppy would be fine. After the reporter had returned home, the puppy had continued to experience seizures. Per the reporter, she had called the veterinarian numerous times on 7/15 and had always been reassured that the puppy just needed to rest and relax. The reporter stated she opted to take the puppy to a different veterinarian on 7/16. According to the reporter, on physical examination that day the puppy┐┐┐s temperature had been 93.9F. He had received IV fluids, and multiple injections including several Atropine injections. The puppy had passed away the evening of 7/16. Note: The product is designed to be used on pets at least 12 weeks of age. In addition, the product is designed to be used on cats and kittens, not dogs and puppies.

To be determined by Registrant

18. Severity classification (if there is more than 1 possible classification


19. Provide supplemental information here